Hideyuki Kuroda

Saitama, 3400203, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases.

JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases.

Journal: International journal of molecular sciences

Published: March 15, 2024

Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus.

Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus.

Journal: BMC endocrine disorders

Published: February 11, 2023

GADD34 activates p53 and may have utility as a marker of atherosclerosis.

GADD34 activates p53 and may have utility as a marker of atherosclerosis.

Journal: Frontiers in medicine

Published: December 21, 2022

Serum anti‑TSTD2 antibody as a biomarker for atherosclerosis‑induced ischemic stroke and chronic kidney disease.

Serum anti‑TSTD2 antibody as a biomarker for atherosclerosis‑induced ischemic stroke and chronic kidney disease.

Journal: Medicine international

Published: September 22, 2022

Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis.

Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis.

Journal: Scientific reports

Published: January 19, 2021

Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.

Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.

Journal: BMC medicine

Published: June 12, 2020

Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases.

Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases.

Journal: Cancer science

Published: April 08, 2020

Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.

Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.

Journal: International journal of molecular medicine

Published: March 25, 2020

Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction.

Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction.

Journal: BMC neurology

Published: March 18, 2020

Circulating Anti-Sorting Nexins 16 Antibodies as an Emerging Biomarker of Coronary Artery Disease in Patients with Obstructive Sleep Apnea.

Circulating Anti-Sorting Nexins 16 Antibodies as an Emerging Biomarker of Coronary Artery Disease in Patients with Obstructive Sleep Apnea.

Journal: Diagnostics (Basel, Switzerland)

Published: December 26, 2019

Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases.

Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases.

Journal: Heliyon

Published: November 19, 2018

Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction.

Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction.

Journal: Oncotarget

Published: August 12, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026